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Abstract
Background: Some of the genus Rhododendron was used in traditional medicine for arthritis, acute and chronic
bronchitis, asthma, pain, inflammation, rheumatism, hypertension and metabolic diseases and many species of the
genus Rhododendron contain a large number of phenolic compounds and antioxidant properties that could be
developed into pharmaceutical products.
Methods: In this study, the antioxidative phytochemicals of Rhododendron oldhamii Maxim. leaves were detected
by an online HPLC–DPPH method. In addition, the anti-hyperuricemic effect of the active phytochemicals from
R. oldhamii leaf extracts was investigated using potassium oxonate (PO)-induced acute hyperuricemia.
Results: Six phytochemicals, including (2R, 3R)-epicatechin (1), (2R, 3R)-taxifolin (2), (2R, 3R)-astilbin (3), hyposide (4),
guaijaverin (5), and quercitrin (6), were isolated using the developed screening method. Of these, compounds 3, 4,
5, and 6 were found to be major bioactive phytochemicals, and their contents were determined to be 130.8 ± 10.9,
105.5 ± 8.5, 104.1 ± 4.7, and 108.6 ± 4.0 mg per gram of EtOAc fraction, respectively. In addition, the four major
bioactive phytochemicals at the same dosage (100 mmol/kg) were administered to the abdominal cavity of
potassium oxonate (PO)-induced hyperuricemic mice, and the serum uric acid level was measured after 3 h
of administration. H&E staining showed that PO-induced kidney injury caused renal tubular epithelium nuclear
condensation in the cortex areas or the appearance of numerous hyaline casts in the medulla areas; treatment with
100 mmol/kg of EtOAc fraction, (2R, 3R)-astilbin, hyposide, guaijaverin, and quercitrin significantly reduced kidney injury.
In addition, the serum uric acid level was significantly suppressed by 54.1, 35.1, 56.3, 56.3, and 53.2 %, respectively, by
the administrations of 100 mmol/kg EtOAc fraction and the derived major phytochemicals, (2R, 3R)-astilbin, hyposide,
guaijaverin, and quercitrin, compared to the PO group. The administration of 10 mg/kg benzbromarone, a well-known
uricosuric agent, significantly reduced the serum uric acid level by 45.5 % compared to the PO group.
Conclusion: The in vivo decrease in uric acid was consistent with free radical scavenging activity, indicating that the
major phytochemicals of R. oldhamii leave extracts and the derived phytochemicals possess potent hypouricemic
effects, and they could be potential candidates for new hypouricemic agents.
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Background
The major function of xanthine oxidase (XOD) is to
catalyze the oxidation of hypoxanthine to xanthine and
to further catalyze the oxidation of xanthine to uric
acid in purine metabolism [1]. Excess amounts of uric
acid in the body result in the deposition of urate crystals
in the joints and kidneys, causing inflammation as well as
gouty arthritis and uric acid nephrolithiasis [2, 3]. Recent
studies also noted that hyperuricemia is associated with a
risk of chronic nephritis, renal dysfunction, cardiovascular
diseases, hypertension, diabetes, and metabolic syndrome
[4, 5]. Thus, there has been increasing interest in the
search of more effective or novel bioactive compounds in
order to improve the insufficient uric acid excretion from
a wide variety of traditional herbal plants [6–8].
The genus Rhododendron is widely distributed through-
out most of the world, with the exception of Africa and
South America [9]. Some members of the genus Rhodo-
dendron were used in traditional medicine for arthritis,
acute and chronic bronchitis, asthma, pain, inflamma-
tion, rheumatism, hypertension, and metabolic diseases
[10–12]. In addition, Rhododendron sp. used in Unani
system of medicine for treatment of gout [13, 14]. Re-
cent studies have shown that many species of the genus
Rhododendron contain a large number of phenolic
compounds and antioxidant properties that could be
developed into pharmaceutical products [15, 16]. In
addition, recent studies noted that phenolics are strong
XOD-inhibitors [17] and have the potential to lower
the risk of hyperuricemia and gout [18]. In previous
studies, it was found that Rhododendron yedoense con-
tains large amounts of flavonoids and shows excellent
XOD-inhibitory activities [19]. Therefore, methanolic
extracts of R. oldhamii leaves may be good candidates
for further development as clinically relevant anti-
hyperuricemic agents. However, to the best of our
knowledge, there are no prior reports on R. oldhamii leaf
extracts and its derivatives possessing antioxidant activity
in vitro and hyperuricemic activity in vivo. Therefore, in
this study, we investigated the hypouricemic effect of a
methanolic extract and its major phytochemicals from
R. oldhamii leaves in mice for the first time.
Methods
Chemicals
Benzbromarone, potassium oxonate, 1,1’-diphenyl-2-
picrylhydrazyl radical (DPPH.), hypoxanthine, xanthine
oxidase, nitroblue tetrazolium chloride (NBT), Folin-
Ciocalteu reagent, potassium dihydrogen phosphate
(KH2PO4), and (+)-catechin were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). The other
chemicals and solvents used in this experiment were
HPLC-grade.
Plant materials
The leaves of Rhododendron oldhamii Maxim. from
Lion Head Mountain of Taipei county in Taiwan (Lat.
24°56'16"N., Long. 121°30'07"E.) were collected at the
end of April 2011. The voucher specimen (voucher no. 6)
was deposited at the herbarium of the Department of
Forestry and Natural Resources, National Chiayi University
(NCYU), Taiwan. The species were identified by Dr.
Lei-Chen Lin (NCYU). The materials were air dried
at ambient temperature (25 °C) and stored in a
refrigerator at 4 °C prior to treatments.
Extraction, fractionation, and isolation
Leaves were soaked in methanol at ambient temperature
for 7 days. The extracts were decanted and filtered
through Whatman No.1 filter paper, and the filtrates
were concentrated in a rotary evaporator and then ly-
ophilized. Furthermore, the resulting methanolic crude
extracts of R. oldhamii were successively fractionated
with n-hexane, ethyl acetate (EtOAc), n-butanol (BuOH),
and water to yield soluble fractions of hexane, EtOAc,
BuOH, and water. The phytochemicals from the EtOAc
fraction were separated and purified by semi-preparative
HPLC on a Jasco PU-2080 instrument (Tokyo, Japan)
equipped with a MD-2010 photo-diode array detector
(Jasco) and a 250 mm × 10.0 mm i.d., 5-μm Supelco RP-
amide column (Bellefonte, PA, USA). The mobile phase
was solvent A, 100 % MeOH; and solvent B, ultrapure
water. The elution conditions were 0–15 min of 30–
60 % A to B (linear gradient); 15–20 min of 60–65 % A
to B (linear gradient); 20–27 min of 65–100 % A to B
(linear gradient); and 27–40 min of 100–100 % A to B
at a flow rate of 4 mL/min. ESI-MS data were collected
by a Finnigan MAT-95S mass spectrometer, and NMR
spectra were recorded by a Bruker Avance 500 MHz FT-
NMR spectrometer. The structures of compound 1,
compound 2, compound 3, compound 4, compound 5,
and compound 6 were identified by ESI-MS and NMR.
Quantification
The phytochemicals were quantified by LC-MS (Thermo,
Dioxed UltiMate 3000 UHPLC; Bruker, amazon speed)
with a 250 mm × 4.6 mm i.d., 2.6-μm C-18 column
(Phenomenex, Torrance, CA, USA). The mobile phase
was solvent A, 100 % MeOH; and solvent B, ultrapure
water. The elution conditions were 0–15 min of 30–60 %
A to B (linear gradient); 15–20 min of 60–65 % A to B
(linear gradient); 20–27 min of 65–100 % A to B (linear
gradient); and 27–40 min of 100–100 % A to B at a
flow rate of 0.5 mL/min using a detector. For the
preparation of the calibration curve, standard stock
solutions of compounds were prepared in methanol,
filtered through Millipore filters (0.45 μm), and appro-
priately diluted to obtain the desired concentrations in the
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quantification range. The calibration graphs were
plotted after the linear regression of the peak areas
versus concentrations.
DPPH radical-scavenging activity (DPPH assay)
The scavenging activity of the DPPH free radical by the
test samples was determined according to the method
reported by Ho et al. [20]. Ten μL of the test samples was
mixed with 200 μL of 0.1 mM DPPH-ethanol solution and
90 μL of 50 mM Tris–HCl buffer (pH 7.4). Methanol
(10 μL) alone was used as the control in this experiment.
After 30 min of incubation at room temperature, the
reduction in DPPH free radicals was measured by reading
the absorbance at 517 nm using a Thermo Scientific
Multiskan GO microplate reader (Vantaa, Finland).
(+)-Catechin was used as the positive control. The
inhibition ratio was calculated using the following
equation: % inhibition = [(absorbance of control– absorb-
ance of test sample)/ absorbance of control] × 100.
Superoxide radical-scavenging activity (NBT assay)
The measurement of superoxide radical-scavenging
activity was carried out using the method described by
Tung et al. [21], and (+)-catechin was used as the stand-
ard. First, 20 μL of 15 mM Na2EDTA in buffer (50 mM
KH2PO4/KOH, pH 7.4), 50 μL of 0.6 mM NBT in buffer,
30 μL of 3 mM hypoxanthine in 50 mM KOH, 5 μL of
the test samples in methanol, and 145 μL of buffer were
mixed in 96-well microplates (Falcon, USA). The reac-
tion was initiated by adding 50 μL of a xanthine oxidase
solution in buffer (1 unit in 10 mL buffer) to the
mixture. The reaction mixture was incubated at room
temperature, and the absorbance at 570 nm was deter-
mined every 20 s up to 5 min using a plate reader. The
control was 5 μL of methanol instead of the sample
solution. (+)-Catechin was used as the positive control.
The inhibition ratio was calculated using the following
equation: % Inhibition = [(rate of control – rate of sample -
reaction)/ rate of control] × 100.
Reducing power assay
This assay was determined according to the method re-
ported by Lin et al. [16], with slight modifications. Briefly,
1 mL of the reaction mixture containing 500 μL the test
extracts or compounds in 500 μL phosphate buffer
(0.2 M, pH 6.6) was incubated with 500 μL potassium
ferricyanide (1 %, w/v) at 50 °C for 20 min. The reaction
was terminated by adding trichloroacetic acid (10 %, w/v),
and the mixture was centrifuged at 3000 rpm for 10 min.
The supernatant solution (500 μL) was mixed with
distilled water (500 μL) and 100 μL of ferric chloride
(0.1 %, w/v) solution, and the absorbance was measured at
700 nm. The reducing ability was expressed as (+)-cat-
echin equivalents (CE) in milligrams per gram sample.
Determination of total phenolics
The total phenolic content was determined according to
the Folin-Ciocalteu method [16], using gallic acid as the
standard. The test sample (5 mg) was dissolved in 5 mL
of methanol/water (50:50, v/v). The extract solution
(500 μL) was mixed with 500 μL of 50 % Folin-Ciocalteu
reagent. The mixture was kept for a 5-min period, which
was followed by the addition of 1.0 mL of 20 % Na2CO3.
After 10 min of incubation at room temperature, the
mixture was centrifuged for 8 min (1200 g) and the
absorbance of the supernatant was measured at 730 nm.
The total phenolic content was expressed as gallic acid
equivalents (GAE) in milligrams per gram sample.
On-line DPPH radical-scavenging analysis
The best antioxidant activity of the extract (EA fraction)
from R. oldhamii leaves was further monitored by the
on-line RP–HPLC–DPPH method. The EA fraction
(stock concentration = 20 mg/mL) was monitored by
analytic HPLC on a model PU-2080 instrument (Jasco,
Japan) with a 250 mm × 10.0 mm i.d., 5-μm Supelco RP-
amide column (Bellefonte, PA, USA). The mobile phase
was solvent A, 100 % MeOH; and solvent B, ultrapure
water. The elution conditions were 0–15 min of 30–
60 % A to B (linear gradient); 15–20 min of 60–65 % A
to B (linear gradient); 20–27 min of 65–100 % A to B
(linear gradient); and 27–40 min of 100–100 % A to B
at a flow rate of 4 mL/min, using a Jasco MD-2010
photo diode array at 280 nm wavelength. For the on-line
DPPH radical-scavenging analysis, the flow of DPPH
reagent (300 mg/L in methanol) was set to 4 mL/min,
and the induced bleaching was detected photometrically
as a negative peak at 517 nm.
Animals
Male ICR mice with a body weight of approximately
30 g (8 weeks old) were purchased from BioLASCO
(A Charles River Licensee Corp., Yi-Lan, Taiwan).
Mice were given a standard laboratory diet and dis-
tilled water ad libitum, and they were kept on a 12-h
light/dark cycle at 22 ± 2 °C. All animal experimental
protocols were approved by the Institutional Animal
Care and Use Committee (IACUC) of National
Taiwan Sport University, and the study conformed to
the guidelines of the protocol IACUC-10319 approved
by the IACUC ethics committee.
Potassium oxonate (PO) − induced hyperuricemia in mice
For the hyperuricemia study, potassium oxonate (PO),
an uricase inhibitor, was employed to induce acute
hyperuricemia according to Tung et al. [22]. Sixty-four
mice were randomly assigned to eight groups for treat-
ment (n = 8 per group): (1) vehicle group; (2) PO group;
(3) PO + BZM group; (4) PO + EA group; (5) PO + AS
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group; (6) PO +HP group; (7) PO + GJ group; and (8)
PO +QR group. Briefly, mice were intraperitoneally (i.p.)
injected with PBS containing PO (200 mg/kg) 1 h before
the test samples were administered to increase the serum
uric acid level. For a comparative study, the same dosage
at 100 mmol/kg of the EtOAc fraction (EA, 45.0 mg/kg),
(2R, 3R)-astilbin (AS, 45.0 mg/kg), hyposide (HP,
46.4 mg/kg), guaijaverin (GJ, 43.4 mg/kg), and quercitrin
(QR, 44.8 mg/kg) dissolved in DMSO were delivered i.p.
for 1 h post PO administration. In this study, 10.0 mg/kg
benzbromarone (BEM), a well-known uricosuric agent,
was used as the reference control.
Pathological histology
Kidney tissue was fixed in 10 % buffered formalde-
hyde and examined using hematoxylin and eosin
(H&E) staining.
Measurement of serum BUN, creatinine, and uric acid level
Blood samples were collected by retro-orbital bleeding
after 3 h PO administration. Blood samples were
centrifuged at 1,400 × g at 4 °C for 15 min, and the
levels of BUN, creatinine and uric acid in the serum
supernatants were measured using an autoanalyzer
(Hitachi 7060, Hitachi, Japan).
Statistical analysis
The data for in vitro and in vivo assays are expressed as
the mean ± SD (n = 3) and the mean ± SEM (n = 8),
respectively. The significance of difference was calcu-
lated by Scheffe’s test, and the results with P < 0.05 were
considered to be statistically significant.
Results and discussion
DPPH radical-scavenging activity of R. oldhamii leaf
extract and its derived soluble fractions
In the present study, the free radical-scavenging activity
of R. oldhamii leaf extract was assessed by a DPPH
assay. Accordingly, as shown in Fig. 1a, the DPPH
radical-scavenging activity of the methanolic extract and
its derived soluble fractions from leaves of R. oldhamii,
including the soluble fractions of n-hexane, EtOAc,
BuOH, and water, were shown in a dose-dependent
manner. Of these, the EtOAc fraction showed the
strongest activity. Meanwhile, except for the n-hexane
and water-soluble fractions, all extracts showed a good
inhibitory activity against the DPPH radicals. The IC50
values (the concentration required to inhibit radical
formation by 50 %) of the crude extract, hexane, EtOAc,
BuOH, and water fraction were 7.5 ± 0.2, 77.6 ± 2.3,
5.0 ± 0.1, 6.1 ± 0.1 and 30.0 ± 0.6 μg/mL, respectively.
The IC50 value of (+)-catechin, a well-known antioxidant
compound used as the reference control in this study,
Fig. 1 Antioxidant activities of the methanolic extract and its derived soluble fractions from the leaves of R. oldhamii. a DPPH radical scavenging
activity. b Superoxide radical scavenging activity. c Reducing power. d Total phenolic contents. The results are presented as the mean ± SD (n = 3).
The bars marked by different letters are significantly different at the level of P < 0.05, according to Scheffe’s test
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was 1.9 ± 0.0 μg/mL. Lin et al. [16] reported that the IC50
values of the crude extracts of Rhododendron species
increased in the following order: R. pseudochrysanthum
(7.5 μg/mL), R. oldhamii (7.5 μg/mL), R. kanehirai
(7.7 μg/mL), R. breviperulatum (8.8 μg/mL), R. rubropilo-
sum var. taiwanalpinum (10.4 μg/mL), R. formosanum
(10.7 μg/mL), R. simsii (11.8 μg/mL), R. rubropilosum var.
rubropilosum (12.1 μg/mL), R. ellipticum (14.2 μg/mL),
and R. mariesii (14.7 μg/mL). These results showed that
the crude extracts of the Rhododendron species exhibited
a good DPPH radical scavenging activity.
Superoxide radical-scavenging activity of R. oldhamii leaf
extract and its derived soluble fractions
Superoxide radical was generated by the hypoxanthine-
xanthine oxidase and NBT systems in this assay. Figure 1b
shows the superoxide radical-scavenging activity of the
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Fig. 2 a The online HPLC–DPPH chromatograms of the EtOAc fraction from R. oldhamii leaf extract. b Isolated and identified phytochemicals:
(2R, 3R)-epicatechin (1), (2R, 3R)-taxifolin (2), (2R, 3R)-astilbin (3), hyposide (4), guaijaverin (5), and quercitrin (6)
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oldhamii leaves compared with (+)-catechin. At the
10 μg/mL test concentration, the superoxide radical inhib-
ition of R. oldhamii leaf extract and its derived fractions
decreased in the following order: BuOH fraction
(49.6 %) > EtOAc fraction (42.6 %) > crude extract
(37.7 %) > water fraction (9.1 %) > n-hexane fraction
(4.7 %). The IC50 values of (+)-catechin, crude extract,
n-hexane fraction, EtOAc fraction, BuOH fraction,
and water fraction were 15.1 ± 0.5, 18 ± 2.1, 433.1 ± 9.0,
11.1 ± 0.4, 9.6 ± 0.6, and 60.1 ± 4.8 μg/mL, respectively.
The comparisons of these data revealed that the crude
extract, the EtOAc fraction, and the BuOH fraction exam-
ined in this study exhibited great superoxide radical-
scavenging activity. The present study revealed that the
EtOAc fraction and the BuOH fraction showed excellent
performances in superoxide radical inhibition and their in-
hibitory activities were better than that of (+)-catechin.
Lin et al. [16] showed that among all soluble fractions
from R. pseudochrysanthum leaves, both the EtOAc frac-
tion and the BuOH fraction exhibited the best superoxide
radical-scavenging activity. This may be because the major
components of the EtOAc and BuOH fractions were fla-
vonoids and phenolic acids, which have great superoxide
radical-scavenging effects.
Reducing power of R. oldhamii leaf extract and its derived
soluble fractions
The reducing power of the crude extract and its
derived fractions was calculated as (+)-catechin equiv-
alents (CE) in milligrams per gram sample. As shown
in Fig. 1c, the reducing power of the EtOAc fraction
(367.9 ± 6.3 mg/g) was higher than that of the BuOH
fraction (357.4 ± 9.3 mg/g), the crude extract (285.2 ±
4.1 mg/g), the water fraction (89.3 ± 2.8 mg/g), and the
hexane fraction (19.5 ± 0.5 %). These results revealed that
the EtOAc fraction possessed the highest antioxidant activ-
ity, which was the same as the DPPH radical-scavenging
activity results. These results imply that there is an abun-
dance of antioxidative phytochemicals present in the
EtOAc fraction.
Total phenolic contents of R. oldhamii leaf extract and its
derived soluble fractions
Phenolic compounds are commonly found in the plant
kingdom, and they have been reported to have multiple
biological effects [23, 24]. A correlation between the
content of phenolic compounds and antioxidant activ-
ities has been described in many studies [25–27]. The
phenolic compounds are very important plant constitu-
ents because of their ability to scavenge free radicals.
Figure 1d shows the content of total phenolics in the
crude extract and its derived fractions calculated as
gallic acid equivalents (GAE) in milligrams per gram of
sample. Apparently, the total phenolic content of the
EtOAc fraction (330.3 ± 3.1 mg/g) was higher than that of
the BuOH fraction (295.4 ± 2.9 mg/g), the crude extract
(217.6 ± 2.4 mg/g), the water fraction (66.4 ± 7.2 mg/g),
and the hexane fraction (16.6 ± 0.6 mg/g). These results
imply that there were abundant antioxidative phytochemi-
cals present in the leaf extract of R. oldhamii, especially in
the EtOAc fraction.
On-line RP–HPLC–DPPH method
The on-line RP–HPLC–DPPH method can be used for a
rapid assessment of pure antioxidant compounds in
complex mixtures, particularly plant extracts [28]. The
more rapidly the absorbance decreases, the more potent
the antioxidant activity of the compound will be in
terms of hydrogen-donating ability [29]. The combined
UV (positive signals) and DPPH• quenching (negative
signals) chromatograms under gradient conditions of the
EtOAc fraction from the leaf extract of R. oldhamii are
presented in Fig. 2a. Several eluted phytocompounds in
the EtOAc fraction were detected and gave positive
peaks on the UV detector (280 nm). Among them, (2R,
3R)-epicatechin (1), (2R, 3R)-taxifolin (2), (2R, 3R)-astil-
bin (3), hyposide (4), guaijaverin (5), and quercitrin (6)
(Fig. 2b) showed a hydrogen-donating capacity (nega-
tive peak) towards the DPPH radical at the applied
concentration. The results revealed that the method
can be applied for a quick screening of antioxidant
compounds or to more precisely determine the radical-
scavenging activity of compounds. Thus, it is no longer
necessary to isolate and purify non-target phytocom-
pounds, leading to very significant reductions in costs
and faster results.
Quantification and antioxidant activities of major active
compounds in leaf extract of R. oldhamii
According to the screening results from the on-line
RP–HPLC–DPPH system, (2R, 3R)-epicatechin (1),
(2R, 3R)-taxifolin (2), (2R, 3R)-astilbin (3), hyposide
Table 1 Antioxidant activities and contents of major








(2R, 3R)-Epicatechin (1) 15.0 ± 0.3 8.4 ± 0.2a 34.1 ± 1.3a
(2R, 3R)-Taxifolin (2) 27.0 ± 0.4 7.6 ± 0.2abc 17.9 ± 1.0b
(2R, 3R)-Astilbin (3) 130.8 ± 10.9 8.2 ± 0.5ab 33.2 ± 1.7a
Hyperoside (4) 105.5 ± 8.5 6.8 ± 0.4c 16.1 ± 0.3bc
Guaijaverin (5) 104.1 ± 4.7 7.4 ± 0.1bc 15.8 ± 0.4bc
Quercitrin (6) 108.6 ± 4.0 6.9 ± 0.2c 13.0 ± 0.9c
Different letters within a column indicate significant difference at the P < 0.05
level according to Scheffe’s test
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(4), guaijaverin (5) and quercitrin (6) were found to
be the major bioactive phytochemicals in the EtOAc frac-
tion, and their contents were determined to be 15.0 ± 0.3,
27.0 ± 0.4, 130.8 ± 10.9, 105.5 ± 8.5, 104.1 ± 4.7, and
108.6 ± 4.0 mg per gram of EtOAc fraction, respect-
ively (Table 1). To determine the antioxidant activities
of these major active compounds, DPPH and NBT
assays were performed. As shown in Table 1, the IC50
values for the DPPH radical-scavenging activity of these
major phytochemicals were 8.4 ± 0.2, 7.6 ± 0.2, 8.2 ± 0.5,
6.8 ± 0.4, 7.4 ± 0.1, and 6.9 ± 0.2 μM, respectively.
However, for superoxide radical-scavenging activity,
the IC50 values of these compounds were 34.1 ± 1.3,
17.9 ± 1.0, 33.2 ± 1.7, 16.1 ± 0.3, 15.8 ± 0.4, and 13.0 ±
0.9 μM, respectively. The DPPH and NBT assays
showed that compounds 4, 5 and 6 had better activ-
ities. These results demonstrated that flavonoids
containing the 2,3 double bond in the C ring have
better antioxidant activities. In contrast, flavans have
a saturated heterocyclic C ring, and the consequent
lack of conjugation between the A and B rings means
that electrons are less able to be delocalized from the


















Fig. 3 The pathological histology of the EtOAc fraction and its derived phytochemicals of R. oldhamii leaf extract in PO-induced hyperuricemic
mice. The H&E staining showed that PO-induced kidney injury caused renal tubular epithelial nuclear condensation (karyopyknosis) in the cortex
or the appearance of numerous hyaline casts in the medulla areas. The levels of renal tubular epithelial nuclear condensation or numerous hyaline
casts were significantly reduced by benzbromarone, the EtOAc fraction, (2R, 3R)-astilbin, hyposide, guaijaverin, and quercitrin treatments
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Anti-hyperuricemic effect in hyperuricemic mice
Benzbromarone and allopurinol are widely used for the
treatment of hyperuricemia. Allopurinol inhibits ROS
production by working as an XO inhibitor but not as a
radical scavenger, whereas benzbromarone decreases
ROS production directly and indirectly by working as
both a uric acid transporter 1 inhibitor and radical
scavenger [30]. In this study, the major compounds of R.
oldhamii leaf extract were good radical scavengers.
Thus, the anti-hyperuricemic effect of R. oldhamii leaf
extract and its phytochemicals on PO-induced hyperuri-
cemia in mice was studied, and benzbromarone was the
reference control used in this study. The hyperuricemic
mice were generated by a single intraperitoneal injection
of PO (200 mg/kg). PO, a urate oxidase inhibitor, can
raise the serum uric acid concentration by inhibiting the
decomposition of uric acid by uricase [31]. H&E staining
showed that PO-induced kidney injury caused renal
tubular epithelium nuclear condensation (karyopyknosis)
in the cortex or the appearance of numerous hyaline
casts in the medulla areas (Fig. 3). The levels of renal
tubular epithelial nuclear condensation or numerous
hyaline casts were significantly reduced after the adminis-
tration of 100 mmol/kg of EtOAc fraction, (2R, 3R)-astil-
bin, hyposide, guaijaverin, and quercitrin. Xiong et al. [32]
also exhibited that NF-κB plays a role in the pathogenesis
of chronic glomerulonephritis, and rhododendron root
may attenuate renal damages by downregulating the
activation of NF-κB. The hyperuricemic animals 3 h after
i.p. of PO exhibited higher serum levels of BUN (40.2 ±
1.2 mg/dL), creatinine (0.44 ± 0.02 mg/dL), and uric acid
(2.9 ± 0.3 mg/dL) when compared to the vehicle control
group (16.6 ± 0.7, 0.10 ± 0.01, and 0.8 ± 0.1 mg/dL, re-
spectively). Therefore, at 3 h post PO injection, the serum
uric acid level showed a more than 3-fold increase com-
pared with the vehicle control (P < 0.05). The administra-
tion of benzbromarone (10 mg/kg) significantly reduced
the serum uric acid level by 45.5 % compared to the PO
group. At an equimolar dose (100 mmol/kg), animals
treated with the EtOAc fraction, (2R, 3R)-astilbin, hypo-
side, guaijaverin, and quercitrin showed a significant re-
duction in uric acid by 54.1, 35.1, 56.3, 56.3, and 53.2 %,
respectively, compared to the PO group (P < 0.05) (Fig. 4).
In addition, treating hyperuricemic mice with benzbro-
marone, the EtOAc fraction, (2R, 3R)-astilbin, hyposide,
guaijaverin, and quercitrin slightly reduced both creatinine
and uric acid serum levels. Wang et al. [33] reported that
cinnamaldehyde had good inhibitory activity on xanthine
oxidase activity and could significantly reduce the serum
uric acid level by 60 % compared with the PO group at a
dosage of 150 mg/kg. Tung et al. [22] reported that the
flavonoids of Acacia confusa heartwood, (−)-2,3-cis-3,4-cis-
3,3’,4,4’,7,8-hexahydroxyflavan, (−)-2,3-cis-3,4-cis-4’-meth-
oxy- 3,3’,4,7,8-pentahydroxyflavan, melanoxetin, transilitin,
and okanin, showed good inhibitory activity on xanthine
oxidase activity, and significantly reduced the serum uric
acid level by 66, 72, 75, 65 and 69 %, respectively, com-
pared with the PO group. Zhu et al. [34] also found that
administration of the flavonoids quercetin and rutin
significantly reduced the serum uric acid level by 36 %
and 32 %, respectively, at dosages of 150 mg/kg. Compari-
sons of the aforementioned results indicated that the







































































Fig. 4 The reductions in serum BUN, creatinine, and the uric acid level
by the EtOAc fraction and its derived phytochemicals of R. oldhamii
leaf extract in PO-induced hyperuricemic mice. The results are
presented as the mean ± SEM of eight mice. Different letters are
significantly different at the level of P < 0.05 according to the
Scheffe’s test
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excellent effect on reducing urate levels. Among the
flavonoid constituents examined, hyposide, guaijaverin,
and quercitrin were comparable with benzbromarone and
showed an excellent effect on reducing urate levels.
Conclusion
It is well-known that ROS have a high correlation with
several diseases, such as ageing, atherosclerosis, inflam-
matory injury, cancer, and cardiovascular disease. This
study demonstrated, for the first time, that among the
leaf extracts of R. oldhamii, the EtOAc fraction exhibited
the highest antioxidant activity. Thus, the EtOAc frac-
tion was applied to the online HPLC–DPPH method,
and six specific and excellent antioxidants were detected
and identified. In addition, the study also demonstrated
that the major constituents of R. oldhamii leaf extracts
possessed potent in vivo hypouricemic effects in hyper-
uricemic mice pretreated with potassium oxonate. Thus,
the dietary use of R. oldhamii leaf extracts and their
constituents may provide some options for the preven-
tion and/or treatment of hyperuricemia.
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